Clinical trials carried out in emerging countries such as India and China are now subject to the same standards as those conducted in developed countries, an industry-sponsored report reveals 1 ,2.
While there have been “legitimate concerns” in the past about clinical trials conducted in emerging countries, things have improved “enormously” over the last ten to 15 years, says the report commissioned by the Association of Clinical Research Organizations, which represents the global CRO industry...
Please login to read the full article.
